Quironsalud Madrid
| Turchia | Austria | Spagna | |
| Immunoterapia con Keytruda (Pembrolizumab) | da $3,300 | da $15,000 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore della vescica. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore della vescica e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore della vescica.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.
She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.
Il dottor Luis Madero — oncologo pediatrico con 37 anni di esperienza nel trattamento delle malattie del sangue, nel trapianto di midollo osseo, nella terapia ablativa e in altre patologie. È membro di diverse associazioni e possiede una vasta esperienza nel suo campo.
Dr. Javier Romero Otero is a specialist in prostatic pathology, andrology, and reconstructive genital surgery. He is the Director of HM Hospitales in Madrid and Medical Director of ROC Global Health. He also teaches at Complutense University of Madrid.
He leads the R&D group in comprehensive male health. Dr. Romero Otero has published over 70 research papers in PubMed-indexed journals and contributed to more than 25 book chapters. He serves on editorial committees for several specialized journals. He has presented over 200 papers at scientific conferences and holds important roles in scientific associations in his field.